These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 16927597)

  • 1. [Hyperhomocysteinemia and B-vitamin deficiency. Current clinical aspects].
    Herrmann W; Herrmann M; Obeid R
    Med Monatsschr Pharm; 2006 Aug; 29(8):291-302. PubMed ID: 16927597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Review of the role of hyperhomocysteinemia and B-vitamin deficiency in neurological and psychiatric disorders--current evidence and preliminary recommendations].
    Herrmann W; Lorenzl S; Obeid R
    Fortschr Neurol Psychiatr; 2007 Sep; 75(9):515-27. PubMed ID: 17729191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of hyperhomocysteinemia.
    Herrmann W
    Clin Lab; 2006; 52(7-8):367-74. PubMed ID: 16955635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rationale and design for the CARDIOVIT Study (Cardiovit, Atherosclerotic vascular disease and hypeRhomocysteinemia: an epiDemiological study in Indians, additionally evaluating the effect of Oral VITamin supplementation).
    Shenoy KT; Lena KB; Sali N; Syam S; Shenoy ST; Rajadhyaksha VD; Pai GP; Shaikh AA;
    Curr Med Res Opin; 2006 Apr; 22(4):641-8. PubMed ID: 16684424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Homocysteine-lowering trials for prevention of heart disease and stroke.
    Clarke R
    Semin Vasc Med; 2005 May; 5(2):215-22. PubMed ID: 16047274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Homocysteine and coronary heart disease.
    Clarke R; Lewington S
    Semin Vasc Med; 2002 Nov; 2(4):391-9. PubMed ID: 16222629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is plasma homocysteine a modifiable risk factor for stroke?
    Hankey GJ
    Nat Clin Pract Neurol; 2006 Jan; 2(1):26-33. PubMed ID: 16932518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ischemic stroke and hyperhomocysteinemia: truth or myth?
    Terwecoren A; Steen E; Benoit D; Boon P; Hemelsoet D
    Acta Neurol Belg; 2009 Sep; 109(3):181-8. PubMed ID: 19902811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperhomocysteinemia: a new risk factor for degenerative diseases.
    Herrmann W; Knapp JP
    Clin Lab; 2002; 48(9-10):471-81. PubMed ID: 12389706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stroke: roles of B vitamins, homocysteine and antioxidants.
    Sánchez-Moreno C; Jiménez-Escrig A; Martín A
    Nutr Res Rev; 2009 Jun; 22(1):49-67. PubMed ID: 19555518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homocysteine and cardiovascular risk in patients with diabetes mellitus.
    Yeromenko Y; Lavie L; Levy Y
    Nutr Metab Cardiovasc Dis; 2001 Apr; 11(2):108-16. PubMed ID: 11434188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperhomocysteinemia: clinical and therapeutical involvement in venous thrombosis.
    Hoţoleanu C; Porojan-Iuga M; Rusu ML; Andercou A
    Rom J Intern Med; 2007; 45(2):159-64. PubMed ID: 18333369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New cardiovascular risk factors: homocysteine and vitamins involved in homocysteine metabolism.
    De Caterina R; Zampolli A; Madonna R; Fioretti P; Vanuzzo D
    Ital Heart J; 2004 Jun; 5 Suppl 6():19S-24S. PubMed ID: 15185912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contributions of hyperhomocysteinemia to atherosclerosis: Causal relationship and potential mechanisms.
    Zhou J; Austin RC
    Biofactors; 2009; 35(2):120-9. PubMed ID: 19449439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homocysteine and vitamin therapy in stroke prevention and treatment: a review.
    Manolescu BN; Oprea E; Farcasanu IC; Berteanu M; Cercasov C
    Acta Biochim Pol; 2010; 57(4):467-77. PubMed ID: 21140003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-induced pertubation of the aminothiol redox-status in patients with epilepsy: improvement by B-vitamins.
    Apeland T; Frøyland ES; Kristensen O; Strandjord RE; Mansoor MA
    Epilepsy Res; 2008 Nov; 82(1):1-6. PubMed ID: 18644700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homocysteine and coronary atherosclerosis: from folate fortification to the recent clinical trials.
    Antoniades C; Antonopoulos AS; Tousoulis D; Marinou K; Stefanadis C
    Eur Heart J; 2009 Jan; 30(1):6-15. PubMed ID: 19029125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High plasma homocysteine is associated with the risk of coronary artery disease independent of methylenetetrahydrofolate reductase 677C-->T genotypes.
    Lin PT; Huang MC; Lee BJ; Cheng CH; Tsai TP; Huang YC
    Asia Pac J Clin Nutr; 2008; 17(2):330-8. PubMed ID: 18586656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical relevance of homocysteine monitoring in the diabetic patient].
    Benmerabet S; Fredenrich A; Robillon JF; Canivet B; Candito M; Van Obberghen E
    Diabetes Metab; 2002 Dec; 28(6 Pt 1):510-5. PubMed ID: 12522334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormones and homocysteine.
    Asnani S; Desouza C; Homan J; Murthy SN; McNamara DB; Fonseca V
    Minerva Endocrinol; 2002 Sep; 27(3):141-55. PubMed ID: 12091790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.